We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $27B
1-Year Est. Return 24.49%
This Fund
S&P 500
This Quarter Est. Return
-0.29%
1 Year Est. Return
+24.49%
3 Year Est. Return
+88.53%
5 Year Est. Return
+114.58%
10 Year Est. Return
+419.26%
AUM
$9.57B
AUM Growth
-$135M
Cap. Flow
-$62.3M
Cap. Flow %
-0.65%
Top 10 Hldgs %
17.19%
Holding
1,945
New
104
Increased
419
Reduced
880
Closed
82

Sector Composition

Rank Sector Weight
1 Technology 16.92%
2 Financials 15.77%
3 Healthcare 13.04%
4 Industrials 10.64%
5 Consumer Discretionary 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPXC
1676
DELISTED
RPX Corporation
RPXC
$10K ﹤0.01%
950
FNSR
1677
DELISTED
Finisar Corp
FNSR
$10K ﹤0.01%
640
-100
-14% -$1.89K
AAT
1678
American Assets Trust
AAT
$1.4B
$9K ﹤0.01%
260
-200
-43% -$6.79K
BJRI icon
1679
BJ's Restaurants
BJRI
$1.48B
$9K ﹤0.01%
210
-150
-42% -$6.04K
BRKL
1680
DELISTED
Brookline Bancorp
BRKL
$9K ﹤0.01%
550
-250
-31% -$4.09K
CASH icon
1681
Pathward Financial
CASH
$1.8B
$9K ﹤0.01%
240
HSII
1682
DELISTED
Heidrick & Struggles
HSII
$9K ﹤0.01%
300
-200
-40% -$5.46K
JOE icon
1683
St. Joe Company
JOE
$3.83B
$9K ﹤0.01%
480
-350
-42% -$6.48K
LQDT icon
1684
Liquidity Services
LQDT
$1.32B
$9K ﹤0.01%
1,400
MNRO icon
1685
Monro
MNRO
$398M
$9K ﹤0.01%
170
-100
-37% -$5.55K
MYGN icon
1686
Myriad Genetics
MYGN
$312M
$9K ﹤0.01%
+300
New +$10.2K
NVAX icon
1687
Novavax
NVAX
$1.31B
$9K ﹤0.01%
+215
New +$8.64K
RARE icon
1688
Ultragenyx Pharmaceutical
RARE
$2.55B
$9K ﹤0.01%
+175
New +$8.81K
RYAM icon
1689
Rayonier Advanced Materials
RYAM
$610M
$9K ﹤0.01%
400
-400
-50% -$7.83K
SGMO
1690
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$9K ﹤0.01%
485
-675
-58% -$14.4K
USNA icon
1691
Usana Health Sciences
USNA
$286M
$9K ﹤0.01%
110
WW
1692
DELISTED
WW International
WW
$9K ﹤0.01%
135
-225
-63% -$14.4K
MTUS icon
1693
Metallus
MTUS
$898M
$9K ﹤0.01%
570
-100
-15% -$1.68K
TPC
1694
Tutor Perini Cor
TPC
$5.21B
$9K ﹤0.01%
420
RAVN
1695
DELISTED
Raven Industries Inc
RAVN
$9K ﹤0.01%
270
-150
-36% -$5.36K
MNTA
1696
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$9K ﹤0.01%
480
-300
-38% -$5K
AKS
1697
DELISTED
AK Steel Holding Corp
AKS
$9K ﹤0.01%
1,980
-550
-22% -$3.02K
MDR
1698
DELISTED
McDermott International
MDR
$9K ﹤0.01%
+475
New +$10.9K
ONCE
1699
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$9K ﹤0.01%
135
-75
-36% -$4.33K
TYPE
1700
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$9K ﹤0.01%
410
-200
-33% -$4.81K

Similar funds

Nisa Investment Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Nisa Investment Advisors held 1,945 positions worth $9.57B, down 1.4% from $9.71B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nisa Investment Advisors's Q1 2018 filing shows 104 new, 419 increased, 880 reduced and 82 closed positions. Its largest new stake was Wingstop: 22,550 shares worth $1.03M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $33.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Nisa Investment Advisors's largest Q1 2018 buy was Wingstop: 22,550 shares worth $1.03M.
  • Nisa Investment Advisors added most to iShares Core S&P 500 ETF in Q1 2018, an estimated $52M increase.
  • Nisa Investment Advisors's biggest Q1 2018 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $33.4M.
  • Nisa Investment Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $2.74M.
  • Nisa Investment Advisors's ten largest holdings make up 17% of its $9.57B portfolio in Q1 2018.
  • Nisa Investment Advisors opened 104 new positions and closed 82 in Q1 2018.
  • Nisa Investment Advisors's portfolio value fell 1.4% quarter-over-quarter to $9.57B.

Based on Nisa Investment Advisors's 13F filing for Q1 2018, filed 10 Apr 2018.